• An All-Too-Common Question In Pharma Marketing: What Is Holding Us Back?
    A quick scan of pharma industry articles and blogs often get me excited with all the chatter of new app features, hot new social communities offering patients deeper ways to connect, or the promise of robust and actionable data we can incorporate from all of our quantified-self gadgets. With all that vigor and excitement we strive each day to deliver the best thinking for our client, embracing all these elements as we counsel and guide strategy. But all too often I see brand managers holding back, taking the wait-and-see approach, and missing opportunities to transform their category.
  • Relationships Need To Adapt, Too
    We live in a multifaceted and complex time for healthcare. It seems like more people are getting ill with chronic and terminal conditions, and there are more challenges to getting the proper care. So the need for creating healthcare communications and experiences that respond to these challenges has gotten more complicated as well.
  • Patients, Not Users: Humanizing The Mobile Health Movement
    As mobile technology and healthcare continue to evolve, people are increasingly turning to the devices in their pocket to provide everything from calorie counting to glucose monitoring. According to Digitas' mBook Report, 90% of patients say they would use an app "prescribed" by their doctor (even though only 66% would fill a medical prescription), and a report by Grand View Research, Inc. says the global market for Mobile Healthcare (mHealth) applications is projected to exceed $42 billion by 2020.
  • What Life Sciences Marketers Can Learn From Hollywood About Buying Consulting And Agency Services
    Recently, The New York Times published an article headlined, "What Hollywood Can Teach Us About the Future of Work." In it, the author marvels at the "Hollywood model" of work: where ad hoc teams carry out large and complex projects, requiring diverse talents with complementary skills. Per the article: "A project is identified; a team [of contractors] is assembled; it works together for precisely as long as is needed to complete the task; then the team disbands."
  • The Art And Science Of Effective Work
    Chuck Porter, chief strategist at MDC Partners, gave a lovely talk on creativity at the Cannes Lions Advertising Festival last year. In the Q&A that followed, someone in the audience asked him a question he did not understand. The person asked again, a little louder, but Chuck still didn't understand. Someone fetched a microphone and we all heard the question. Chuck still didn't get it. The question was asking how a great creative mind reconciles the difference between highly effective and highly awarded work.
  • The Synergy Between Call Centers And Population Health
    Healthcare is evolving from a fee-for-service and volume-driven model to one that is value based. The Centers for Medicare & Medicaid Services has stepped up its timeline for shifting Medicare to a value-based system so that by the end of 2016, at least 30% of fee-for-service Medicare payments will be tied to value through accountable care organizations or bundled payment arrangements. By the end of 2018, that number will increase to 50%.
  • Pharma And Digital Innovation: A Missed Opportunity?
    The "Wall Street Journal" suggests that entrepreneurs and innovators are not paying enough attention to the growing and pressing needs of pharmaceutical companies in the digital health arena. But is this really the case?
  • Pharma's Guide To Being 'Smart' About The Apple Watch
    While the Apple Watch still rolls out to the initial pre-order customers, the pharma industry is making changes. Android has rolled out major updates to Android Wear to compete with the Apple Watch and app developers are lining up to add to the over 3,500 existing Apple Watch enabled apps. But what about you? What is your plan to understand how this new screen will impact your efforts?
  • Pharma Moves Into Digital Health
    The announcement that Novartis and Qualcomm Ventures have formed a joint venture to invest $100 million in digital health is significant and suggests that big pharma is transitioning from talk to action in the strategy to "move beyond the pill."
  • Why The Future Of Healthcare Will Be Smarter Than The Past
    Last night, I was at a graduate student class presentation at NYU on the future of media. The focus was on four scenarios around automation, surveillance, semantic web, and the rise of women as global catalysts. Thought-provoking as each scenario was, it got me thinking about the future of healthcare in exactly these terms - the role of automation from treatment decision support to robot-assisted surgery, the activation of remote tracking and monitoring of patient compliance and biometrics, peer-enabled learning and disease management for both physicians and patients, and the role of gender, race, and genetics in screening and treating ...
« Previous Entries Next Entries »